ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
21.394,93
-0,11%
S&P 500
6.101,24
-0,29%
Dow Jones
44.424,25
-0,32%
Euro vs US Dollar
1,05025
0,00%
Bitcoin
104.978,58
0,24%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. SIGA Technologies Inc (SIGA) Börsenkurse

SIGA Technologies Inc

SIGA Technologies Inc (SIGA)

NASDAQ
6,45
-0,02
(-0,31%)
Geschlossen 26 Januar 10:00PM
Verzögert um 15 Minuten
6,45
0,005
(0,08%)
Nach Börsenschluss: 12:56AM
Verzögert um 15 Minuten

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Wichtige Statistiken und Details

Current Price
6,45
Gebot
6,45
Fragen
6,57
Volumen
263.815
6,395 Tagesbereich 6,61
4,26 52-Wochen-Bereich 12,83
Marktkapitalisierung
460,56M
Handelsende
6,47
Handelsbeginn
6,49
Letzte Trade
20
@
6.45
Letzter Handelszeitpunkt
Finanzvolumen
US$ 1.702.443
VWAP
6,4532
Durchschnittliches Volumen (3 Mio.)
488.696
Ausgegebene Aktien
71.404.669
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
6,76
Gewinn pro Aktie (EPS)
0,95
Erlöse
139,92M
Nettogewinn
68,07M

Über SIGA Technologies Inc

SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's lead product is TPOXX, an orally administered antiviral drug for the treatment of human smallpox disease caused by the variola virus. Its products target orthopoxvirus infections i... SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's lead product is TPOXX, an orally administered antiviral drug for the treatment of human smallpox disease caused by the variola virus. Its products target orthopoxvirus infections including smallpox. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Diversified
Website
www.siga.com
Hauptsitz
Wilmington, Delaware, USA
Gegründet
1995
SIGA Technologies Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SIGA. The last closing price for SIGA Technologies was US$6,47. Over the last year, SIGA Technologies shares have traded in a share price range of US$ 4,26 to US$ 12,83.

SIGA Technologies currently has 71.404.669 shares in issue. The market capitalisation of SIGA Technologies is US$461,99 million. SIGA Technologies has a price to earnings ratio (PE ratio) of 6.76.

SIGA Neueste Nachrichten

Weitere Nachrichten

TEPOXX (tecovirimat) Approved in Japan for the Treatment of Orthopoxviruses

Regulatory decision marks first approval in Japan of an antiviral for the treatment of orthopoxviruses including smallpox, mpox and cowpoxJapan Biotechno Pharma Co., Ltd. engaged as exclusive...

02 Januar 2025
GlobeNewswire Inc.

Form 8-K - Current report

13 Dezember 2024
Edgar (US Regulatory)

Form 8-K - Current report

10 Dezember 2024
Edgar (US Regulatory)

Interim Results from STOMP Study of SIGA’s Tecovirimat in Treatment of Mpox Announced

Interim analysis shows that tecovirimat did not improve time to lesion resolution compared to placebo in adults with mild to moderate clade II mpoxStudy stopped enrolling patients in all study...

10 Dezember 2024
GlobeNewswire Inc.

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

08 November 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

07 November 2024
Edgar (US Regulatory)

Form 8-K - Current report

07 November 2024
Edgar (US Regulatory)

SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2024

Product Revenues for the Three and Nine months Ended September 30, 2024 were $9 million and $53 million, respectivelyReceived $122 Million of Procurement Orders from the U.S. Government in the...

07 November 2024
GlobeNewswire Inc.

SIGA to Host Business Update Call on November 7 Following Release of Third-Quarter 2024 Financial Results

NEW YORK, Oct. 31, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and...

31 Oktober 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

29 Oktober 2024
Edgar (US Regulatory)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.15632.483435816776.29376.456.1653008406.31529827CS
40.457.566.585.753782036.22699037CS
12-0.85-11.64383561647.37.975.6154886966.56883328CS
26-3.18-33.02180685369.6312.835.6159549938.77070246CS
521.3426.22309197655.1112.834.268468208.33252742CS
1560.243.864734299526.2126.994.215221894212.69349578CS
2601.2423.80038387725.2126.993.96143443212.2279809CS

SIGA - Frequently Asked Questions (FAQ)

What is the current SIGA Technologies share price?
The current share price of SIGA Technologies is US$ 6,45
How many SIGA Technologies shares are in issue?
SIGA Technologies has 71.404.669 shares in issue
What is the market cap of SIGA Technologies?
The market capitalisation of SIGA Technologies is USD 461,99M
What is the 1 year trading range for SIGA Technologies share price?
SIGA Technologies has traded in the range of US$ 4,26 to US$ 12,83 during the past year
What is the PE ratio of SIGA Technologies?
The price to earnings ratio of SIGA Technologies is 6,76
What is the cash to sales ratio of SIGA Technologies?
The cash to sales ratio of SIGA Technologies is 3,29
What is the reporting currency for SIGA Technologies?
SIGA Technologies reports financial results in USD
What is the latest annual turnover for SIGA Technologies?
The latest annual turnover of SIGA Technologies is USD 139,92M
What is the latest annual profit for SIGA Technologies?
The latest annual profit of SIGA Technologies is USD 68,07M
What is the registered address of SIGA Technologies?
The registered address for SIGA Technologies is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the SIGA Technologies website address?
The website address for SIGA Technologies is www.siga.com
Which industry sector does SIGA Technologies operate in?
SIGA Technologies operates in the PHARMACEUTICAL DIVERSIFIED sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
NVNINVNI Group Ltd
US$ 4,38
(193,96%)
366,98M
EVAXEvaxion Biotech AS
US$ 5,99
(64,56%)
55,41M
ELABPMGC Holdings Inc
US$ 3,0901
(56,07%)
76,48M
PCLAPicoCELA Inc
US$ 4,60
(49,35%)
3,75M
GOEVCanoo Inc
US$ 0,475
(43,94%)
282,22M
GODNUGolden Star Acquisition Corporation
US$ 3,11
(-75,82%)
17,51k
GODNGolden Star Acquisition Corporation
US$ 2,93
(-65,67%)
902,76k
NXTTNext Technology Holding Inc
US$ 1,37
(-54,93%)
2,56M
SGLYSingularity Future Technology Ltd
US$ 1,625
(-38,45%)
917,77k
WHLRLWheeler Real Estate Investment Trust Inc
US$ 90,11
(-38,07%)
8
ACONAclarion Inc
US$ 0,0557
(28,94%)
811,91M
NVNINVNI Group Ltd
US$ 4,38
(193,96%)
366,98M
RIMEAlgorhythm Holdings Inc
US$ 0,0357
(4,69%)
284,97M
GOEVCanoo Inc
US$ 0,475
(43,94%)
282,22M
NVDANVIDIA Corporation
US$ 142,62
(-3,12%)
232,88M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
SIGA
SIGA Technologies
BIT
UB7RUQ
Unicredit Bank
BIT
VECP
Vanguard Eur Corporate B...
BIT
HYEM
VanEck Emerging Markets ...
BIT
CRPA
Exchange Traded
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten